The Hippo pathway regulates the YAP and TAZ transcriptional coactivators, which are often upregulated in human cancers. YAP/TAZ partner with TEAD transcription factors to drive cancer phenotypes. Because mutations in the Hippo pathway genes NF2 and LATS2 lead to YAP/TAZ hyperactivation, mesothelioma...